• 1. Fe3O4@PANI: a magnetic polyaniline nanomaterial for highly efficient and handy enrichment of intact N-glycopeptides??
  Zhizhen Lai,Mo Zhang,Jinyu Zhou,Tianjing Chen,Dan Li,Xuejing Shen,Jia Liu,Jiang Zhou,Zhili Li Analyst, 2021,146, 4261-4267
• 2. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726
• 3. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 4. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 5. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782

Comprehensive Overview of tert-butyl N-[(3R)-4,4-dimethylpyrrolidin-3-yl]carbamate (CAS No. 219323-15-6)

tert-butyl N-[(3R)-4,4-dimethylpyrrolidin-3-yl]carbamate, with the CAS number 219323-15-6, is a specialized organic compound widely utilized in pharmaceutical research and fine chemical synthesis. This chiral carbamate derivative is particularly valued for its role as a key intermediate in the development of bioactive molecules, including potential drug candidates targeting neurological and metabolic disorders. The compound's unique stereochemical configuration and functional group compatibility make it a versatile building block in asymmetric synthesis.

Recent trends in medicinal chemistry highlight growing interest in pyrrolidine-based scaffolds, with researchers frequently searching for terms like "chiral pyrrolidine synthesis" or "carbamate protecting groups." The tert-butyloxycarbonyl (Boc) group in this compound offers excellent stability under various reaction conditions while allowing selective deprotection – a feature extensively discussed in forums about "amine protection strategies." Its 4,4-dimethyl substitution pattern contributes to enhanced steric hindrance, a property increasingly important in designing molecules with improved target selectivity.

From a synthetic perspective, CAS 219323-15-6 demonstrates remarkable utility in peptide mimetics development, an area receiving heightened attention due to advances in protein-protein interaction inhibitors. The compound's (3R)-configuration aligns with current industry preferences for enantiomerically pure intermediates, as evidenced by rising searches for "R-configured heterocycles" and "chiral auxiliary applications." Analytical techniques for characterizing this material, including chiral HPLC methods and optical rotation measurements, represent additional frequently queried topics among synthetic chemists.

The pharmaceutical applications of tert-butyl N-[(3R)-4,4-dimethylpyrrolidin-3-yl]carbamate extend to several emerging therapeutic areas. Its structural features appear in investigations of GPCR modulators and enzyme inhibitors, particularly those addressing neurodegenerative conditions – a subject generating substantial online discussion. The compound's rigid pyrrolidine core satisfies contemporary drug design principles emphasizing conformational restriction, while its carbamate functionality permits diverse derivatization opportunities often explored in "structure-activity relationship" studies.

Industrial-scale production of 219323-15-6 incorporates advanced catalytic asymmetric synthesis methods, reflecting the growing demand for green chemistry approaches in fine chemical manufacturing. Process chemists frequently investigate "stereoselective pyrrolidine formation" and "Boc protection optimization" – search terms that underscore the technical relevance of this compound. Recent patent literature reveals innovative applications of this intermediate in kinase inhibitor syntheses, further validating its importance in modern drug discovery pipelines.

Quality control protocols for tert-butyl N-[(3R)-4,4-dimethylpyrrolidin-3-yl]carbamate emphasize rigorous enantiomeric purity assessment, addressing one of the most critical concerns in chiral compound procurement. Analytical discussions frequently reference "chiral purity determination" techniques and "spectroscopic characterization" methods, highlighting the compound's role in advancing analytical methodology development. The stability profile of this material under various storage conditions represents another area of practical interest for laboratory managers and procurement specialists.

Emerging research directions involving CAS 219323-15-6 include its potential incorporation into bioconjugates and prodrug systems, topics gaining traction in pharmaceutical innovation circles. The compound's balanced lipophilicity profile makes it particularly suitable for drug delivery applications, coinciding with increased searches for "brain-penetrating molecules" and "blood-brain barrier transport" strategies. These applications position the compound at the intersection of multiple cutting-edge therapeutic development areas.

Regulatory considerations for tert-butyl N-[(3R)-4,4-dimethylpyrrolidin-3-yl]carbamate focus on standard handling procedures for laboratory chemicals, with particular attention to industrial hygiene practices during large-scale operations. The compound's classification under various chemical inventories and its safety data sheet specifications represent common queries among compliance officers and environmental health professionals in the chemical industry.

• 219323-14-5(tert-butyl N-[(3S)-4,4-dimethylpyrrolidin-3-yl]carbamate)
• 152513-88-7(tert-butyl N-{5-azaspiro[2.4]heptan-7-yl}carbamate)
• 147459-52-7(tert-butyl N-(3-methylpyrrolidin-3-yl)carbamate)
• 127199-44-4(tert-butyl N-[(7R)-5-azaspiro[2.4]heptan-7-yl]carbamate)
• 107610-73-1(tert-butyl N-[trans-4-methylpyrrolidin-3-yl]carbamate)
• 319906-53-1(tert-butyl N-[(3S,4R)-4-methylpyrrolidin-3-yl]carbamate)
• 127199-45-5(tert-butyl N-[(7S)-5-azaspiro[2.4]heptan-7-yl]carbamate)
• 927652-04-8(tert-butyl N-[(3S)-3-methylpyrrolidin-3-yl]carbamate)
• 1334481-84-3(tert-butyl N-[(3R,4S)-4-methylpyrrolidin-3-yl]carbamate)
• 107610-69-5(tert-butyl N-[cis-4-methylpyrrolidin-3-yl]carbamate)